WHO ICTRP trial
ACONDICIONAMIENTO DEL DONANTE CADÁVER MEDIANTE LA ADMINISTRACIÓN DE…
EUCTR2009-013398-16-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2009-013398-16-ES |
|---|---|
| Public title | ACONDICIONAMIENTO DEL DONANTE CADÁVER MEDIANTE LA ADMINISTRACIÓN DE TIMOGLOBULINA PARA DISMINUIR EL ESTADO PRO-INFLAMATORIO TRAS LA MUERTE CEREBRAL |
| Scientific title | ACONDICIONAMIENTO DEL DONANTE CADÁVER MEDIANTE LA ADMINISTRACIÓN DE TIMOGLOBULINA PARA DISMINUIR EL ESTADO PRO-INFLAMATORIO TRAS LA MUERTE CEREBRAL |
| Primary sponsor | Rafael Selgas |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Eficacia: Demostrar que la administración de timoglobulina en el donante cadáver reduce la expresividad antigénica del injerto, mediante una disminución de la expresión de marcadores de inflamación en la biopsia de los injertos. Seguridad… |
| Interventions | Trade Name: TIMOGLOBULINA Pharmaceutical Form: Powder and solvent for solution for infusion INN or Proposed INN: AGUA PARA PREPARACIONES INYECTABLES Other descriptive name: AGUA PARA PREPARACIONES INYECTABLES Concentration unit: ml… |
| Registration date | Aug 27, 2009 |
| Target size | 10 |
| Secondary IDs | HULP-Nefro001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: